Blue Jays reliever García undergoes thoracic outlet surgery, will enter free agency
Toronto Blue Jays reliever García underwent thoracic outlet surgery in Dallas, ending his season and sending him to free agency after repeated rehab setbacks.
The Blue Jays confirmed Tuesday that García had surgery to address thoracic outlet syndrome, a nerve-compression condition between the collarbone and first rib. Manager John Schneider relayed the update to reporters, noting the procedure follows a diagnosis made in early August. García’s operation delivers a definitive end to a season in which he never threw for the major league club while attempting to recover from prior elbow surgery.
Surgery details and diagnosis
García was diagnosed with thoracic outlet syndrome in early August after experiencing symptoms consistent with nerve compression in the shoulder-girdle area. The team opted for surgical intervention in Dallas to treat the condition. Manager John Schneider communicated the decision publicly, framing the operation as necessary given the player’s persistent symptoms and interrupted rehab attempts.
Season context and prior elbow surgery
The right-hander did not appear in a major-league game this year as he continued rehabilitation from right elbow surgery performed during the off-season. That previous operation kept García off the Blue Jays’ active roster throughout the campaign. Attempts to return were repeatedly curtailed by new issues that emerged during minor-league rehab outings, preventing a sustained comeback.
Rehab performance and medical setbacks
Across nine rehabilitation appearances this year, García logged 7.2 innings, recording eight strikeouts while allowing eight earned runs. Those short outings were punctuated by multiple removals from rehab assignments after fresh injuries or setbacks. The pattern of interrupted comeback efforts culminated in the thoracic outlet diagnosis and the decision to proceed with surgery.
Contract status and free agency implications
At 35 years old, García is in the final season of a two-year, $15-million contract he signed prior to the 2025 season. He made just 22 major-league appearances during the term of that deal, compiling a 3.86 ERA and a 1.19 WHIP over 21 innings last season. With the season-ending operation, García will reach free agency coming off another significant procedure, a factor that figures to shape how teams evaluate him on the open market.
Bullpen impact for the Blue Jays
García’s surgery removes a veteran right-handed option from Toronto’s bullpen depth chart for the remainder of the season. The club will need to rely on other relievers already on the roster or promote arms from the minors to cover workload and late-inning matchups. The timing of the operation narrows the Blue Jays’ margin for bullpen reinforcements as they assess trade and internal promotion options.
García’s medical status and contract situation underscore the fragility of reliever health and the ripple effects it can have on roster construction. The player’s combination of prior elbow surgery and now thoracic outlet correction will be central to any offseason discussions with interested teams.
